Rosit

Rosit may be available in the countries listed below.

Ingredient matches for Rosit

Rosiglitazone

Rosiglitazone is reported as an ingredient of Rosit in the following countries:

• Bangladesh

International Drug Name Search

Wincl N

Wincl N may be available in the countries listed below.

Ingredient matches for Wincl N

Nicergoline

Nicergoline is reported as an ingredient of Wincl N in the following countries:

• Japan

International Drug Name Search

Omeprazol Heumann

Omeprazol Heumann may be available in the countries listed below.

Ingredient matches for Omeprazol Heumann

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Heumann in the following countries:

• Germany

International Drug Name Search

Lévocétirizine Teva

Lévocétirizine Teva may be available in the countries listed below.

Ingredient matches for Lévocétirizine Teva

Levocetirizine

Levocetirizine dihydrochloride (a derivative of Levocetirizine) is reported as an ingredient of Lévocétirizine Teva in the following countries:

• France

International Drug Name Search

Axillin

Axillin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Axillin

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Axillin in the following countries:

• France

International Drug Name Search

Tiopental

Tiopental may be available in the countries listed below.

Ingredient matches for Tiopental

Thiopental

Thiopental Sodium is reported as an ingredient of Tiopental in the following countries:

• Argentina


• Colombia

International Drug Name Search

Ramipril Ranbaxy

Ramipril Ranbaxy may be available in the countries listed below.

Ingredient matches for Ramipril Ranbaxy

Ramipril

Ramipril is reported as an ingredient of Ramipril Ranbaxy in the following countries:

• Austria


• Finland


• France


• Netherlands

International Drug Name Search

Lexiva

Lexiva is a brand name of fosamprenavir, approved by the FDA in the following formulation(s):

LEXIVA (fosamprenavir calcium - suspension; oral)

• 
  Manufacturer: VIIV HLTHCARE
  
  Approval date: June 14, 2007
  
  Strength(s): EQ 50MG BASE/ML ^[RLD]

LEXIVA (fosamprenavir calcium - tablet; oral)

• 
  Manufacturer: VIIV HLTHCARE
  
  Approval date: October 20, 2003
  
  Strength(s): EQ 700MG BASE ^[RLD]

Has a generic version of Lexiva been approved?

No. There is currently no therapeutically equivalent version of Lexiva available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lexiva. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Prodrugs of aspartyl protease inhibitors
  Patent 6,436,989
  Issued: August 20, 2002
  Inventor(s): Michael R.; Hale & Roger D.; Tung & Christopher T.; Baker & Andrew; Spaltenstein
  Assignee(s): Vertex Pharmaceuticals, Incorporated
  The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.
  
  Patent expiration dates:
  
  
  • December 24, 2017
    
    ✓ 
    Patent use: TREATMENT OF HIV INFECTION
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • June 24, 2018
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate
  Patent 6,514,953
  Issued: February 4, 2003
  Inventor(s): Ian Gordon; Armitage & Andrew David; Searle & Hardev; Singh
  Assignee(s): SmithKline Beecham Corporation
  The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate, to processes for its preparation, and to its use in the treatment of diseases caused by retroviruses.
  
  Patent expiration dates:
  
  
  • July 15, 2019
    
    ✓ 
    Patent use: TREATMENT OF HIV INFECTION
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • January 15, 2020
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Lexiva Consumer Information (Drugs.com)
• Lexiva Consumer Information (Wolters Kluwer)
• Lexiva Suspension Consumer Information (Wolters Kluwer)
• Lexiva Consumer Information (Cerner Multum)
• Lexiva Advanced Consumer Information (Micromedex)
• Lexiva AHFS DI Monographs (ASHP)
• Fosamprenavir Consumer Information (Wolters Kluwer)
• Fosamprenavir Suspension Consumer Information (Wolters Kluwer)
• Fosamprenavir Consumer Information (Cerner Multum)
• Fosamprenavir Advanced Consumer Information (Micromedex)
• Fosamprenavir Calcium AHFS DI Monographs (ASHP)

Simvastatin-RPM

Simvastatin-RPM may be available in the countries listed below.

Ingredient matches for Simvastatin-RPM

Simvastatin

Simvastatin is reported as an ingredient of Simvastatin-RPM in the following countries:

• Luxembourg

International Drug Name Search

Medifungol

Medifungol may be available in the countries listed below.

Ingredient matches for Medifungol

Clotrimazole

Clotrimazole is reported as an ingredient of Medifungol in the following countries:

• Argentina

International Drug Name Search

Ranidil

Ranidil may be available in the countries listed below.

Ingredient matches for Ranidil

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranidil in the following countries:

• Italy

International Drug Name Search

Vanco-saar

Vanco-saar may be available in the countries listed below.

Ingredient matches for Vanco-saar

Vancomycin

Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Vanco-saar in the following countries:

• Germany

International Drug Name Search